Obagi Medical Products, Inc. (OMPI) Tops Q4 EPS by 5c
Get Alerts OMPI Hot Sheet
Join SI Premium – FREE
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q4 EPS of $0.24, $0.05 better than the analyst estimate of $0.19. Revenue for the quarter came in at $30.6 million versus the consensus estimate of $30.64 million.
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Trends (CTRN) Misses Q4 EPS by 27c, Misses on Revenue; Offers Guidance
- Caleres (CAL) Tops Q4 EPS by 1c, Tops on Revenue; Offers Guidance
- Redwood Trust (RWT) and CPP Investments Enter $750M Strategic Capital Partnership
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!